These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27448183)

  • 1. Multiple sclerosis: Dimethyl fumarate is coming of age.
    Tintoré M; Sastre-Garriga J
    Nat Rev Neurol; 2016 Aug; 12(8):436-7. PubMed ID: 27448183
    [No Abstract]   [Full Text] [Related]  

  • 2. Teaching Neuro
    Tsivgoulis G; Papadimitropoulos GN; Katsanos AH; Zompola C; Safouris A; Kargiotis O; Voumvourakis K
    Neurology; 2017 Oct; 89(15):e188-e189. PubMed ID: 28993534
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythema nodosum in a patient with multiple sclerosis on dimethyl fumarate.
    Algahtani H; Shirah B; Marghalani S; Algarni A
    Mult Scler Relat Disord; 2019 Feb; 28():155-158. PubMed ID: 30597324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower extremity deep venous thrombosis in a multiple sclerosis patient on dimethyl fumarate.
    Mirmosayyeb O; Fayyazi E; Shaygannejad V; Esmaeil N
    Mult Scler Relat Disord; 2018 Oct; 25():196. PubMed ID: 30099205
    [No Abstract]   [Full Text] [Related]  

  • 5. Dimethyl fumarate downregulates the immune response through the HCA
    von Glehn F; Dias-Carneiro RPC; Moraes AS; Farias AS; Silva VAPG; Oliveira FTM; Silva CEBG; de Carvalho F; Rahal E; Baecher-Allan C; Santos LMB
    Mult Scler Relat Disord; 2018 Jul; 23():46-50. PubMed ID: 29763776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic gastroenteritis in a woman with multiple sclerosis on dimethyl fumarate.
    Purchiaroni F; Salvetti M; Buscarinu MC; Annibale B
    Neurology; 2016 Aug; 87(9):952-3. PubMed ID: 27466473
    [No Abstract]   [Full Text] [Related]  

  • 7. Dimethyl fumarate induced migrating polyarthralgias.
    Villedon de Naide M; Moisset X; Soubrier M
    Joint Bone Spine; 2019 May; 86(3):399-400. PubMed ID: 30081200
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis.
    Mantero V; Abate L; Basilico P; Balgera R; Salmaggi A; Nourbakhsh B; Cordano C
    J Neurol; 2021 Jun; 268(6):2023-2025. PubMed ID: 32588182
    [No Abstract]   [Full Text] [Related]  

  • 9. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.
    Smith MD; Calabresi PA; Bhargava P
    Eur J Immunol; 2018 Feb; 48(2):380-383. PubMed ID: 29108094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
    Makhani N; Schreiner T
    Pediatr Neurol; 2016 Apr; 57():101-4. PubMed ID: 26996405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dimethylfumarate in the treatment of relapsing-remitting multiple sclerosis].
    Popova EV; Boyko AN; Orlova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10 Pt 2):68-72. PubMed ID: 28139614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review.
    Yoon EL; Cheong WL
    Mult Scler Relat Disord; 2019 Feb; 28():104-108. PubMed ID: 30590239
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE approval of dimethyl fumarate could benefit thousands living with relapsing-remitting multiple sclerosis.
    Boulicault D; Duddy M
    Neurodegener Dis Manag; 2015; 5(1):7-10. PubMed ID: 25711449
    [No Abstract]   [Full Text] [Related]  

  • 14. Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis.
    Hosseini A; Masjedi A; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Anvari E; Jadidi-Niaragh F
    J Cell Physiol; 2019 Jul; 234(7):9943-9955. PubMed ID: 30536402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate.
    Bollo L; Caputo F; Paolicelli D; Trojano M; Iaffaldano P
    Intern Emerg Med; 2022 Sep; 17(6):1845-1847. PubMed ID: 35486330
    [No Abstract]   [Full Text] [Related]  

  • 16. Diroximel fumarate to treat multiple sclerosis.
    Wang Y; Bhargava P
    Drugs Today (Barc); 2020 Jul; 56(7):431-437. PubMed ID: 32648853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies.
    Montes Diaz G; Hupperts R; Fraussen J; Somers V
    Autoimmun Rev; 2018 Dec; 17(12):1240-1250. PubMed ID: 30316988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question.
    Pistono C; Osera C; Boiocchi C; Mallucci G; Cuccia M; Bergamaschi R; Pascale A
    Pharmacol Res; 2017 Jun; 120():279-293. PubMed ID: 28396093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
    Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
    Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study.
    Gold R; Arnold DL; Bar-Or A; Hutchinson M; Kappos L; Havrdova E; MacManus DG; Yousry TA; Pozzilli C; Selmaj K; Sweetser MT; Zhang R; Yang M; Potts J; Novas M; Miller DH; Kurukulasuriya NC; Fox RJ; Phillips TJ
    Mult Scler; 2017 Feb; 23(2):253-265. PubMed ID: 27207449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.